Genome wide association study (GWAS) (see Methods: Transcriptome-based phenome-wide association study) found that the genetic variants of CD209 were associated with multiple diseases, including asthma (the top among detected associations, p=1.0×10−13), cancers and neurological disorders (Supplementary Table S2), showing their possible underlying links involving DCs and/or Mø (which also express CD209 on surface). This evidence concerns the gene CD209 and cancer.